Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category

Anti-PI4 kinase beta/PI4KB antibody (ab246880)

Anti-PI4 kinase beta/PI4KB antibody (ab246880)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

You may also be interested in

Product image
Ciglitazone, PPARgamma agonist (ab141139)
D,L-Buthionine-(S,R)-sulfoximine, gamma-glutamyl cysteine synthase inhibitor (ab144943)
Product image
Recombinant Mouse Calreticulin protein (His tag) (ab240775)
Product image
Recombinant Outer capsid glycoprotein VP7 (Tagged) (ab238289)

Images

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PI4 kinase beta/PI4KB antibody (ab246880)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PI4 kinase beta/PI4KB antibody (ab246880)

    Paraffin-embedded human stomach tissue stained for PI4 kinase beta/PI4KB using ab246880 at 1/20 dilution in immunohistochemical analysis.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Product image

    Anti-Amisyn antibody - N-terminal (ab153974)

  •  
  • Product image

    Recombinant Human Cofilin protein (ab85154)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.